Mannatech (NASDAQ:MTEX) Stock Passes Below Two Hundred Day Moving Average of $17.46

Shares of Mannatech, Incorporated (NASDAQ:MTEX – Get Rating) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $17.46 and traded as low as $12.51. Mannatech shares last traded at $12.51, with a volume of 1,612 shares traded.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. TheStreet cut shares of Mannatech from a “b-” rating to a “d+” rating in a report on Thursday, April 6th. StockNews.com assumed coverage on shares of Mannatech in a report on Wednesday. They set a “buy” rating on the stock.

Mannatech Price Performance

The company’s fifty day moving average price is $14.88 and its 200 day moving average price is $17.46. The company has a market capitalization of $23.42 million, a P/E ratio of -4.98 and a beta of 1.21. The company has a quick ratio of 0.68, a current ratio of 1.17 and a debt-to-equity ratio of 0.08.

Mannatech (NASDAQ:MTEX – Get Rating) last announced its earnings results on Friday, March 17th. The company reported ($3.78) EPS for the quarter. The business had revenue of $34.34 million for the quarter. Mannatech had a negative return on equity of 26.68% and a negative net margin of 3.26%.

Mannatech Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 30th. Investors of record on Thursday, March 16th were paid a $0.20 dividend. The ex-dividend date of this dividend was Wednesday, March 15th. This represents a $0.80 dividend on an annualized basis and a yield of 6.39%. Mannatech’s dividend payout ratio (DPR) is -31.87%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Mannatech stock. Tower Research Capital LLC TRC grew its stake in shares of Mannatech, Incorporated (NASDAQ:MTEX – Get Rating) by 167.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,575 shares of the company’s stock after buying an additional 987 shares during the quarter. Tower Research Capital LLC TRC owned approximately 0.08% of Mannatech worth $27,000 as of its most recent SEC filing. 24.90% of the stock is owned by institutional investors.

Mannatech Company Profile

(Get Rating)

Mannatech, Inc engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L.